104 related articles for article (PubMed ID: 17070506)
1. Aberrant localization of importin alpha1 in hippocampal neurons in Alzheimer disease.
Lee HG; Ueda M; Miyamoto Y; Yoneda Y; Perry G; Smith MA; Zhu X
Brain Res; 2006 Dec; 1124(1):1-4. PubMed ID: 17070506
[TBL] [Abstract][Full Text] [Related]
2. Notch-1 immunoexpression is increased in Alzheimer's and Pick's disease.
Nagarsheth MH; Viehman A; Lippa SM; Lippa CF
J Neurol Sci; 2006 May; 244(1-2):111-6. PubMed ID: 16473372
[TBL] [Abstract][Full Text] [Related]
3. Abnormal Sp1 transcription factor expression in Alzheimer disease and tauopathies.
Santpere G; Nieto M; Puig B; Ferrer I
Neurosci Lett; 2006 Apr 10-17; 397(1-2):30-4. PubMed ID: 16378688
[TBL] [Abstract][Full Text] [Related]
4. Aluminum in hippocampal neurons from humans with Alzheimer's disease.
Walton JR
Neurotoxicology; 2006 May; 27(3):385-94. PubMed ID: 16458972
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease.
Zhu X; McShea A; Harris PL; Raina AK; Castellani RJ; Funk JO; Shah S; Atwood C; Bowen R; Bowser R; Morelli L; Perry G; Smith MA
J Neurosci Res; 2004 Mar; 75(5):698-703. PubMed ID: 14991845
[TBL] [Abstract][Full Text] [Related]
6. Decreased estrogen receptor-alpha expression in hippocampal neurons in relation to hyperphosphorylated tau in Alzheimer patients.
Hu XY; Qin S; Lu YP; Ravid R; Swaab DF; Zhou JN
Acta Neuropathol; 2003 Sep; 106(3):213-20. PubMed ID: 12819990
[TBL] [Abstract][Full Text] [Related]
7. Neurofibrillary tangles may interfere with Smad 2/3 signaling in neurons.
Chalmers KA; Love S
J Neuropathol Exp Neurol; 2007 Feb; 66(2):158-67. PubMed ID: 17279001
[TBL] [Abstract][Full Text] [Related]
8. Ectopic expression of Musashi-1 in Alzheimer disease and Pick disease.
Lovell MA; Markesbery WR
J Neuropathol Exp Neurol; 2005 Aug; 64(8):675-80. PubMed ID: 16106215
[TBL] [Abstract][Full Text] [Related]
9. Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease.
Takeda T; Uchihara T; Arai N; Mizutani T; Iwata M
Acta Neuropathol; 2009 Jan; 117(1):35-44. PubMed ID: 19002475
[TBL] [Abstract][Full Text] [Related]
10. Coenzyme q induces tau aggregation, tau filaments, and Hirano bodies.
Santa-Mara I; Santpere G; MacDonald MJ; Gomez de Barreda E; Hernandez F; Moreno FJ; Ferrer I; Avila J
J Neuropathol Exp Neurol; 2008 May; 67(5):428-34. PubMed ID: 18431254
[TBL] [Abstract][Full Text] [Related]
11. Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe?
Ogawa O; Zhu X; Lee HG; Raina A; Obrenovich ME; Bowser R; Ghanbari HA; Castellani RJ; Perry G; Smith MA
Acta Neuropathol; 2003 May; 105(5):524-8. PubMed ID: 12677454
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical study of the hnRNP A2 and B1 in the hippocampal formations of brains with Alzheimer's disease.
Mizukami K; Ishikawa M; Iwakiri M; Ikonomovic MD; Dekosky ST; Kamma H; Asada T
Neurosci Lett; 2005 Sep; 386(2):111-5. PubMed ID: 15993539
[TBL] [Abstract][Full Text] [Related]
13. Altered subcellular location of phosphorylated Smads in Alzheimer's disease.
Ueberham U; Ueberham E; Gruschka H; Arendt T
Eur J Neurosci; 2006 Oct; 24(8):2327-34. PubMed ID: 17074053
[TBL] [Abstract][Full Text] [Related]
14. c-Jun phosphorylation in Alzheimer disease.
Thakur A; Wang X; Siedlak SL; Perry G; Smith MA; Zhu X
J Neurosci Res; 2007 Jun; 85(8):1668-73. PubMed ID: 17455299
[TBL] [Abstract][Full Text] [Related]
15. A peptidyl-prolyl isomerase, FKBP12, accumulates in Alzheimer neurofibrillary tangles.
Sugata H; Matsuo K; Nakagawa T; Takahashi M; Mukai H; Ono Y; Maeda K; Akiyama H; Kawamata T
Neurosci Lett; 2009 Aug; 459(2):96-9. PubMed ID: 19414059
[TBL] [Abstract][Full Text] [Related]
16. Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer's disease and tauopathies to granulovacuolar degeneration bodies.
Lagalwar S; Berry RW; Binder LI
Acta Neuropathol; 2007 Jan; 113(1):63-73. PubMed ID: 17089132
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
Chalmers KA; Love S
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
[TBL] [Abstract][Full Text] [Related]
18. Nuclear pore complex proteins in Alzheimer disease.
Sheffield LG; Miskiewicz HB; Tannenbaum LB; Mirra SS
J Neuropathol Exp Neurol; 2006 Jan; 65(1):45-54. PubMed ID: 16410748
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of COX-2 in subdivisions of the hippocampus during aging and in Alzheimer's disease: the Hisayama Study.
Fujimi K; Noda K; Sasaki K; Wakisaka Y; Tanizaki Y; Iida M; Kiyohara Y; Kanba S; Iwaki T
Dement Geriatr Cogn Disord; 2007; 23(6):423-31. PubMed ID: 17457030
[TBL] [Abstract][Full Text] [Related]
20. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
